Sayaka Nagami

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Prognostic Factors

Intensive Care Unit

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

This page only lists publications with an associated author ORCID identifier.

Publications

Midori Shima, Azusa Nagao, Masashi Taki, Tadashi Matsushita, Koichi Oshida, Kagehiro Amano, Sayaka Nagami, Norihiro Okada, Shingo Maisawa, Keiji Nogami
Long-term safety and efficacy of emicizumab for up to 5.8 years and patients' perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)
Midori Shima, Keiji Nogami, Sayaka Nagami, Seitaro Yoshida, Koichiro Yoneyama, Akira Ishiguro, Takashi Suzuki, Masashi Taki
A multicentre, open-label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 25 (6) (2019)